What's in Ophthalmic Consultants of Long Island's pipeline?

Ophthalmic Consultants of Long Island has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Ophthalmic Consultants of Long Island's portfolio?

Top competitors by shared drug class: Allergan, Assistance Publique - Hôpitaux de Paris, Andrew B Adams, Armando Torres Ramírez, Albert Einstein Healthcare Network.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ophthalmic-consultants-of-long-island.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Ophthalmic Consultants of Long Island — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ophthalmic Consultants of Long Island pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Ocular lubricant	Ocular lubricant	marketed	Ophthalmic lubricant		Ophthalmology
Cyclosporine 0.05%	Cyclosporine 0.05%	marketed	Calcineurin inhibitor	Calcineurin	Ophthalmology

Therapeutic area mix

Ophthalmology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allergan · 2 shared drug classes
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Andrew B Adams · 1 shared drug class
Armando Torres Ramírez · 1 shared drug class
Albert Einstein Healthcare Network · 1 shared drug class
Astellas Pharma China, Inc. · 1 shared drug class
Astellas Pharma Europe Ltd. · 1 shared drug class
Al-Azhar University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ophthalmic Consultants of Long Island:

Cite this brief

Drug Landscape (2026). Ophthalmic Consultants of Long Island — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ophthalmic-consultants-of-long-island. Accessed 2026-05-17.